Humana Inc.(HUM)
Humana Inc., together with its subsidiaries, operates as a health and well-being company in the United States. It operates through three segments: Retail, Group and Specialty, and Healthcare Services. The company offers medical and supplemental benefit plans to individuals. It also has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits. In addition, the company provides commercial fully insured medical and specialty health insurance benefits comprising dental, vision, and other supplemental health benefits; and administrative services only products to individuals and employer groups, as well as military services, such as TRICARE T2017 East Region contract. Further, it offers pharmacy solutions, provider services, and home solutions services, such as home health and other services to its health plan members, as well as to third parties. As of December 31, 2021, the company had approximately 17 million members in medical benefit plans, as well as approximately 5 million members in specialty products. Humana Inc. was founded in 1961 and is headquartered in Louisville, Kentucky.
Latest News & Analysis
Humana's Q3 Beat Masks Guidance Concerns as Medical Cost Pressures Persist
Humana exceeded Q3 earnings expectations but cut forward guidance as rising Medicaid and health benefit costs erode the cost discipline narrative.
Humana Pivots to Disciplined Growth as Cost Control Gains Traction
Humana's benefit ratio improves to 88.7%, signalling cost discipline gains in Medicare Advantage despite rising industry medical costs.
Humana's Medicare Advantage Challenges: Strategic Shifts and Market Impact
A comprehensive data-driven analysis of Humana’s Q4 2024 performance, membership decline, CMS star ratings, and strategic market shifts.
Humana News Update (Failed Generation)
Content generation failed - Recovery needed
Humana's Medicare Advantage Crisis: Membership Losses & Star Ratings
Humana Inc. faces significant Medicare Advantage challenges, marked by declining memberships and star rating downgrades amid rising healthcare costs.
Humana's Challenges: Medicare Advantage, Costs, and Strategic Responses in 2025
Humana faces Medicare Advantage challenges, rising costs, and CMS star rating pressures. Strategic responses and market positioning are critical. Read the full analysis.
Humana (HUM) Analysis: Navigating Medicare Advantage Challenges
Humana Inc. faces Medicare Advantage challenges and rising medical costs. Strategic shifts, including kidney care expansion and dividend payments, aim for long-term growth.
Humana (HUM): Navigating Medicare Advantage Headwinds and Expanding Care Services
Humana Inc. navigates Medicare Advantage challenges, rising costs, and strategic shifts. Expansion of kidney care and community support highlight their path forward.
Humana's Medicare Advantage Crisis: Navigating Challenges
Analyzing Humana's challenges in the Medicare Advantage market, including declining star ratings, rising medical costs, and strategic responses.
Humana's Debt Offering: Implications for Investors and Healthcare
Humana's $1.25B debt offering addresses rising medical costs in its Medicare Advantage segment. Strategic moves include cutting plans, value-based care, and lobbying efforts.
Humana Inc. Financial Analysis: Navigating Rising Costs
Humana Inc. faces rising medical costs, particularly in its Medicare Advantage segment, impacting profitability. Strategic initiatives include collaborations and debt management.
Humana (HUM): Strategic Initiatives in Senior Healthcare and Market Analysis
Humana focuses on senior healthcare via CenterWell and partnerships. Debt offering and rising medical costs impact financials. Community commitment through the Humana Foundation.
Humana (HUM): CenterWell Expansion, Icon Health, Financial Analysis
Humana expands CenterWell, partners with Icon Health, and navigates debt offerings amidst rising medical costs. A deep dive into HUM's strategic moves and financial health.
Humana (HUM): Medicare Advantage Boost, Community Health, Legal Risks
Analysis of Humana's Q1 2025 earnings, Medicare Advantage boost, community health impact, legal risks, and financial comparison with UnitedHealth.
Humana (HUM) Navigates Rising Costs and Favorable CMS Rate Changes
Humana faces market volatility amid rising costs, strategic shifts, and favorable CMS rate news, impacting its financial trajectory and competitive stance.
Humana Inc. (HUM) Analysis: Navigating Legal Headwinds & Strategic Growth
Humana Inc. navigates legal challenges and strategic growth. Discover how DOJ investigations, Medicare Advantage reforms, and data initiatives impact HUM stock and its market position.
Humana (HUM) Financial Analysis: Navigating Regulatory & Growth Shifts
Humana navigates federal investigations and policy reforms while leveraging demographic tailwinds and tech innovations to drive senior care growth.
Humana Faces DOJ Probe: Unpacking Financial Risks and Strategic Shifts
Humana is under intense DOJ scrutiny for alleged Medicare Advantage kickbacks, raising significant questions about its financial health and future strategic direction.
Humana Inc. Legal Challenges and Financial Insights: Navigating Medicare Advantage Risks and Market Dynamics
Humana faces DOJ allegations over Medicare Advantage kickbacks amid strong financial metrics, highlighting regulatory risks and strategic imperatives for investors.
Humana Inc. Legal Investigation and Financial Impact Analysis - Monexa AI
Humana Inc. faces a securities investigation amid declining earnings and stock price volatility, impacting its Medicare Advantage growth and investor sentiment.
Humana Inc. Legal Challenges and Strategic Shifts Impacting Financial Outlook - Monexa AI
Humana Inc. faces DOJ kickback allegations, impacting stock and strategy. Explore financials, Medicaid expansion, and competitive dynamics in this detailed update.
Humana's Legal Challenges and Financial Resilience in 2025
Humana faces legal probes over billing practices, impacting stock, while financial data shows resilience despite income dip in 2025.
Humana Inc. Legal Challenges and Financial Analysis: Impact on Growth and Market Position
Explore Humana's recent DOJ allegations, securities probes, and Medicare litigation alongside financial metrics shaping its strategic outlook.
Humana Inc. Q2 2025 Analysis: Legal Challenges, Financial Resilience, and Strategic Growth Insights
Explore Humana's Q2 2025 earnings outlook amid DOJ scrutiny, Medicare Advantage dynamics, and CenterWell expansion, with detailed financial and strategic analysis.
Humana Inc. Q2 2025 Earnings & Strategic Update: Margin Focus, Medicare Advantage, and CenterWell Growth
Humana's Q2 2025 report highlights margin expansion, Medicare Advantage membership shifts, CenterWell growth, and strategic cost management amid regulatory pressures.
Humana Inc. Q2 2025 Earnings Strategy and Financial Analysis | Monexa AI
In Q2 2025, Humana Inc. focuses on margin over volume in Medicare Advantage and expands CenterWell healthcare services, navigating regulatory and competitive challenges.
Humana Inc. Regulatory Challenges and Q2 Earnings Insights | Monexa AI
Explore Humana Inc.'s regulatory risks in Medicare Advantage & Medicaid, recent financial trends, and strategic moves ahead of Q2 earnings.
Humana Inc. Market Analysis: Earnings Catalysts, Star Ratings Litigation, and Growth Drivers
Comprehensive analysis of Humana's latest earnings drivers, star ratings litigation, Medicare Advantage growth, and strategic diversification impacting its fundamentals.
Humana Inc. Strategic Prior Authorization Overhaul and Financial Performance Analysis | Monexa AI
Humana Inc. initiates a major prior authorization overhaul to cut outpatient approvals by 33% by 2026, aiming to boost efficiency and financial performance amid regulatory challenges.
Humana Inc. Prior Authorization Reform and Financial Analysis | Monexa AI
Humana Inc. drives strategic efficiency with prior authorization reforms, impacting costs, provider relations, and financial performance amid healthcare sector shifts.
Humana Inc. Q2 2025 Analysis: Strong CenterWell Growth and Medicare Advantage Stability Propel Earnings
Humana's Q2 2025 earnings beat expectations with CenterWell and Medicare Advantage driving growth amid ongoing litigation risks.
Humana Inc. Q2 2025 Update: Strategic Growth and Cost Management Drive Resilience
Humana Inc. reports strong Q2 2025 results with 9.8% revenue growth, strategic Medicare Advantage retention, CenterWell expansion, and Exact Sciences partnership amid litigation risks.
Humana Inc. (HUM): Guidance Lift and Margin Repair — What the Numbers Actually Say
Humana raised 2025 revenue guidance to at least **$128.12B** and EPS to ~**$17.00**; the beat masks a deep earnings rebase and a cash-generation story that matters for MA strategy.
Humana Inc. (HUM): Revenue Strength Meets Margin Pressure — Strategy Under the Microscope
Humana grew revenue to **$117.76B** in FY2024 (+10.71%) while net income plunged **-51.41%** to **$1.21B**; management is trading short-term margins for long-term value-based care scale.